Recent news on Carboplatin

Dabur Pharma Q4 net up 13 fold  -  May 17, 2007
Economic Times,In the US, the company launched two products -- Paclitaxel and Carboplatin -- during the fiscal and expects a few more approvals for its Abbreviated New

Lung Cancer is the Third Most Common Malignant Disease and the ...  -  May 13, 2007
Fuerteventura Digital,...platinum-based compounds that are marketed and clinically used worldwide as treatment for non-small cell lung cancer (NSCLC): cisplatin and carboplatin.

Telik Announces First Quarter 2007 Financial Results  -  May 3, 2007
PR Newswire (press release),A series of preclinical studies focused on the cellular and molecular correlates of synergistic cancer cell growth inhibition by TELCYTA, carboplatin and

Poniard Pharmaceuticals Announces Treatment Of First Patient With ...  -  May 2, 2007
Medical News Today (press release),...or who have progressed within six months of completing, treatment with first-line platinum-containing chemotherapy (cisplatin or carboplatin).

Coley Pharmaceutical Group Reports First Quarter Financial Results  -  May 3, 2007
PR Newswire (press release),...paclitaxel/carboplatin, compared to the efficacy and safety of chemotherapy alone, for the first-line treatment of advanced Stage IIIb/IV non-small cell

Time Course of Early Response to Chemotherapy in Non–Small Cell ...  -  May 2, 2007
Journal of Nuclear Medicine (subscription)Methods: We studied 16 patients with non–small cell lung cancer as they followed 2 courses of docetaxel and carboplatin. Each patient was studied weekly for

New Research Results Show That Investigational Drug Phenoxodiol ...  -  May 1, 2007
PR Newswire (press release),Multinational trial underway Phenoxodiol in combination with carboplatin is currently being studied in a multi-national Phase III clinical trial called

Oncolytics Biotech Inc. Announces 2007 First Quarter Results  -  Apr 27, 2007
CNW Telbec (Communiqués de presse),...in the US Clinical Trials - Recently Approved to Commence Along with our UK REOLYSIN(R) in combination with paclitaxel and carboplatin clinical trial,

Congressional Hearing: Is Our Food Safe?  -  26 Apr 2007
Market Wire (press release)WHEAT RIDGE, CO -- (MARKET WIRE) -- April 26, 2007 -- GeneThera, Inc. (OTCBB: GTHAE) announced that on April 24, 2007 Congress held hearings to examine the

CuraGen Reports First Quarter 2007 Financial Results and Updated ...  -  26 Apr 2007
Earthtimes.orgPreliminary Phase Ib/II results of intravenous belinostat in combination with carboplatin and paclitaxel for advanced ovarian cancer to be presented in a

OSI Pharmaceuticals Announces Pivotal Phase III Tarceva(R) Study ...  -  26 Apr 2007
Business Wire (press release),...with doublet platinum-based chemotherapy (carboplatin and paclitaxel or gemcitabine and cisplatin) and its use is not recommended in that setting.

Telik Reports Positive New Telcyta Preclinical Data at American ...  -  Apr 18, 2007
PharmaLive.com (press release),One series of studies focused on cellular and molecular correlates of synergistic cancer cell growth inhibition caused by TELCYTA, carboplatin or paclitaxel

Telik Reports Positive New TELCYTA Preclinical Data at American ...  -  Apr 17, 2007
PR-Inside.com (Pressemitteilung),...on cellular and molecular correlates of synergistic cancer cell growth inhibition caused by TELCYTA, carboplatin or paclitaxel alone and in doublet and

Get the latest news direct to your desktop  -  Apr 18, 2007
PipelineReview.com (press release),Patients received standard doses of carboplatin and paclitaxel and one of four doses of TELCYTA (400, 500, 750 or 1000 mg/m2) for a planned course of four

Telik: Telcyta Improves Cancer Survival  -  Apr 17, 2007
Houston Chronicle,...of lung cancer _ were given either Telcyta and the chemotherapy carboplatin along with the cancer drug paclitaxel, or carboplatin and paclitaxel alone.

Telik's Triplet Therapy Works In Phase II Study For NSCLC  -  Apr 18, 2007
Therapeutics Daily (subscription) (press release),Telcyta late last year yielded failures (in two monotherapy trials) or skewed results (in a combination with carboplatin), and shares of Telik took a

Telik Announces Telcyta Clinical and Preclinical Presentations at ...  -  Apr 9, 2007
PR Newswire (press release),Details of the presentations are as follows: -- Phase 2 Multicenter Dose-Ranging Trial of TLK286 (Canfosfamide HCl) in Combination with Carboplatin and

FDA Warns of Possible Bevacizumab Fistula Complication  -  Apr 23, 2007
MedPage Today,It's also approved, with carboplatin and paclitaxel, for first-line treatment of patients with unresectable, locally advanced, recurrent or metastatic

Market Report -- In Play (TELK)  -  Apr 17, 2007
MSN Money2 clinical trial of the triplet combination of Telcyta, carboplatin and paclitaxel in the first-line treatment of advanced non-small cell lung cancer.

Telik (TELK) Reports Highly Statistically Significant TELCYTA Results  -  Apr 17, 2007
StreetInsider.com (subscription),Telik, Inc. (Nasdaq: TELK) presented results from a Phase 2 clinical trial of the triplet combination of TELCYTA, carboplatin and paclitaxel in the

Novartis licences lead cancer candidate from Antisoma  -  Apr 23, 2007
In-PharmaTechnologist.com,Positive results of a Phase II trial of CA4P for patients with advanced imageable malignancies, also in combination with paclitaxel and carboplatin,

Cell Therapeutics Inc. (CTI) Files for Special Protocol Assessment ...  -  Apr 4, 2007
Drug Newswire (press release),..."The basis for this trial is the survival benefit we saw among pre- menopausal women in our STELLAR 3 trial, where the XYOTAX/carboplatin combination

Viventia Biotech announces results of Proxinium antibody in ...  -  Apr 22, 2007
News-Medical.net,The combination of Proxinium with cisplatin, carboplatin, paclitaxel, 5-fluorouracil, and docetaxel resulted in a significant additive cytotoxic effect (p

Erbitux with chemotherapy increases overall survival of head and ...  -  Apr 7, 2007
SpiritIndia,...cisplatin plus 5-fluorouracil (5-FU) or carboplatin plus 5-FU, compared to patients treated with cisplatin plus 5-FU or carboplatin plus 5-FU alone.

Erbitux Increases Overall Survival For Head And Neck Cancer Patients  -  Apr 7, 2007
Medical News Today,Half were given Erbitux in combination with cisplatin plus 5-fluorouracil (5-FU) or carboplatin plus 5-FU, while the other half were treated with cisplatin

Erbitux hits primary endpoint in head and neck cancer trial  -  Apr 4, 2007
Pharma Times (subscription),...cisplatin plus 5-fluorouracil (5-FU) or carboplatin plus 5-FU, compared with patients treated with cisplatin plus 5-FU or carboplatin plus 5-FU alone.

Telik (TELK) To Offer Telcyta Clinical and Preclinical ...  -  Apr 9, 2007
StreetInsider.com (subscription),Telik, Inc. (Nasdaq: TELK) announced that updated clinical data from its multicenter Phase 2 trial of the triplet combination of TELCYTA, carboplatin and

Telik Says Telcyta Clinical And Preclinical Data To Be Presented ...  -  Apr 9, 2007
Trading Markets,...of Telcyta, carboplatin and paclitaxel will be presented at the annual meeting of the American Association for Cancer Research in Los Angeles.

Clinical Trials Update: April 4, 2007  -  Apr 4, 2007
Atlanta Journal Constitution (subscription),...low-grade brain tumors called gliomas can be stopped with the following combination of chemotherapy drugs: carboplatin, vincristine, and temozolomide.

Bio-IT Briefs  -  Apr 24, 2007
Bio-IT World,...median survival by five months when used in combination with a standard chemotherapy regimen of paclitaxel and carboplatin over chemotherapy alone.

Avastin Linked to Potentially Fatal Fistulas  -  Apr 24, 2007
Cancerpage.com,In the company's press release, they report that Avastin was used along with irinotecan, carboplatin, and radiation therapy, followed by maintenance Avastin

Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor ...  -  Apr 19, 2007
PR Newswire (press release),MP470, in combination with carboplatin and paclitaxel in small cell and non-small cell lung cancer lines, showed a significant improvement in tumor response

CuraGen and TopoTarget Announce New Clinical Results With ...  -  Apr 19, 2007
Genetic Engineering News (press release),..."A Phase I/II study of the safety and anti-cancer activity of IV-administered belinostat (PXD101) plus carboplatin (C) or paclitaxel (P),

Viventia biotech reports synergistic effect of its Proxinium(TM ...  -  Apr 18, 2007
CNW Telbec (Communiqués de presse),The combination of Proxinium(TM) with cisplatin, carboplatin, paclitaxel, 5-fluorouracil, and docetaxel resulted in a significant additive cytotoxic effect

Cell Therapeutics, Inc. (CTI) Announces XYOTAX(TM) Has Fast Track ...  -  Apr 12, 2007
Medical News Today (press release),The trial will study XYOTAX in combination with carboplatin versus paclitaxel/carboplatin in female NSCLC patients with performance status of 0,

Pharma Sector: Few Newsmakers Of The Week - Merck, Pfizer, Mylan ...  -  Apr 14, 2007
Trading Markets,The PGT307 trial will study Xyotax in combination with carboplatin versus paclitaxel or carboplatin in female NSCLC patients with performance status of 0,

Total Lymphoid Irradiation and Stem Cell Transplantion Very ...  -  Apr 5, 2007
Cancer Consultants (press release),The current study evaluated a regimen of TLI followed by high-dose etoposide, cyclophosphamide and carboplatin in 32 patients and high-dose chemotherapy

Spectrum Pharmaceuticals Announces Data From Three Oncology ...  -  Apr 20, 2007
Medical News Today (press release),In preclinical studies, satraplatin was active in a number of various tumor models and in cells resistant to cisplatin, carboplatin and oxaliplatin.

Cytokinetics Announces Non-Clinical Trial Data Presented at 2007 ...  -  Apr 19, 2007
PipelineReview.com (press release),...tolerability and pharmacokinetics of ispinesib in combination with a leading anti-cancer therapeutic, one in combination with carboplatin, the second in

Spectrum Pharmaceuticals Announces Data From Three Oncology ...  -  Apr 19, 2007
PR Newswire (press release),In preclinical studies, satraplatin was active in a number of various tumor models and in cells resistant to cisplatin, carboplatin and oxaliplatin.

CuraGen and TopoTarget Announce New Clinical Results With ...  -  Apr 19, 2007
PharmaLive.com (press release),...with other active anti-cancer agents, including 5-FU, carboplatin, paclitaxel, cis-retinoic acid, azacitidine and Velcade(R) (bortezomib) for Injection.

Novartis expands late stage oncology  -  Apr 18, 2007
Ad-Hoc-News (Pressemitteilung),...mediansurvival by five months when used in combination with a standardchemotherapy regimen of paclitaxel and carboplatin over chemotherapyalone.

Telik Posts Positive Cancer Drug Data; Shares Rise  -  Apr 17, 2007
Reuters.uk,Patients received standard doses of the chemotherapies, carboplatin and paclitaxel, and one of four doses of Telcyta. Of the 129 patients in the trial,

Coke, EMC Gain on Earnings  -  Apr 17, 2007
Wall Street Journal (subscription),Telik added 1.24, or 21.1%, to 7.13, after the company said its Phase II trial evaluating the triplet combination of Telcyta, carboplatin and paclitaxel in

J&J shares set positive pharma tone  -  Apr 17, 2007
MarketWatch...data for drug candidate Telcyta in the treatment of advanced lung cancer when used in combination with chemotherapy drugs carboplatin and paclitaxel.

Adherex Announces Two Presentations of ADH-1 Data at 2007 American ...  -  Apr 17, 2007
PharmaLive.com (press release),The first, which began in October 2006, is exploring ADH-1 in combination with three different anti-cancer chemotherapies (docetaxel, carboplatin and

A matter of focus  -  25 Feb 2007
Business Standard,The company has recently secured United States Food and Drug Authority (USFDA) approvals for its carboplatin and paclitaxel injectables, and is seeking more

Newly-Published Study Shows CAELYX(R) Plus Carboplatin to Be ...  -  Feb 16, 2007
netPR.pl (komunikaty prasowe),Standard therapy for recurrent ovarian cancer is a regimen containing paclitaxel and carboplatin. However neurotoxicity is a significant cumulative side

Newly-Published Study Shows CAELYX(R) Plus Carboplatin to Be ...  -  Feb 16, 2007
Earthtimes.orgStandard therapy for recurrent ovarian cancer is a regimen containingpaclitaxel and carboplatin. However neurotoxicity is a significant cumulativeside

Paraplatin®/Cytoxan® a Possible Alternative for Ovarian Cancer  -  Feb 20, 2007
Cancer Consultants (press release),According to an article recently published in the Annals of Oncology, the chemotherapy combination consisting of Paraplatin® (carboplatin) plus Cytoxan®

Lung Cancer Patients More Likely to be Eligible for Surgery After ...  -  Feb 9, 2007
DG NewsPARIS, FRANCE -- February 9, 2007 -- Use of induction chemotherapy with doxetaxel plus carboplatin followed by concomitant chemotherapy/radiotherapy

Chemotherapy resistance and oncogene expression in non–small cell ...  -  Jan 31, 2007
The Journal of Thoracic and Cardiovascular SurgeryMETHODS: Chemotherapy resistance to doublets—carboplatin and paclitaxel, cisplatin and navelbline, cisplatin and docetaxel, and cisplatin and

(PRN) - ChipMOS SCHEDULES FOURTH QUARTER 2006 RESULTS CONFERENCE ...  -  Feb 16, 2007
Bolsamania.com,...(PRN) - Newly-Published Study Shows CAELYX(R) Plus Carboplatin to Be Highly Effective and May Potentially Offer Low Neurotoxicity in Patients With Advanced

Discovery to Market: Fact Sheet  -  Feb 8, 2007
MSU Today,MSU researchers made a serendipitous discovery in the 1960s that led to the widely used cancer drugs cisplatin and carboplatin. MSU acquired patents for the

Genentech: How Much Downside From Avastin News?  -  Feb 22, 2007
Seeking Alpha,...more than 50% of the physicians to shift to low dose Avastin in lung cancer until there is further data on low dose Avastin plus carboplatin and Taxol.

Doxil®/Paraplatin® Effective in Recurrent Ovarian Cancer  -  Feb 21, 2007
Cancer Consultants (press release),...consisting of Doxil® (pegylated liposomal doxorubicin) and Paraplatin® (carboplatin) may improve survival in patients with relapsed ovarian cancer.

Pro-Pharmaceuticals Collaborates with Chemwerth to Scale-up ...  -  Feb 20, 2007
PharmaLive.com (press release),Chemwerth offers one of the broadest lines of injectable grade oncology products in the US, including, Amifostine, Carboplatin USP, Cisplatin USP,

Poor-Prognosis Germ Cell Tumors: We Have Not Yet Crossed The ...  -  Feb 19, 2007
Medical News Today (press release),...cycles of BEP followed by 2 cycles of high dose chemotherapy with carboplatin, etoposide, and cyclophosphamide and autologous stem cell rescue on day 5.

Coley Pharmaceutical Group Reports Fourth Quarter and Full Year ...  -  Feb 15, 2007
Earthtimes.org...chemotherapy regimens (paclitaxel/carboplatin or gemcitabine/cisplatin) as compared to the efficacy and safety of standard chemotherapy alone.

Camptosar® Evaluated in Children with Relapsed or Refractory ...  -  Feb 14, 2007
Cancer Consultants (press release),Adriamycin® (doxorubicin), Actinomycin D® (dactinomycin), Vepesid® (etoposide), Platinol® (cisplatin), and Paraplatin® (carboplatin).

Camptosar® Confirmed Active in Recurrent or Refractory ...  -  Feb 13, 2007
Cancer Consultants (press release),Ifex® (ifosfamide), Adriamycin® (doxorubicin), Actinomycin D® (dactinomycin), Vepesid® (etoposide), Platinol® (cisplatin) and Paraplatin® (carboplatin).

Dabur Pharma, Hospira likely to part ways  -  Feb 7, 2007
Moneycontrol.com,Having bagged US Food and Drug Administration approvals for its Carboplatin and Paclitaxel injectables, Dabur Pharma has big plans for the UK and the US for

Dose-Intensive Chemotherapy with Stem Cell and Neupogen® Support ...  -  Feb 5, 2007
Cancer Consultants (press release),A randomized phase III study that intensified doses of ICE (ifosfamide, carboplatin, and etoposide) administered with autologous stem cell and Neupogen

Dose-intensive Chemotherapy Improves Survival for Patients with ...  -  Feb 2, 2007
Cancer Consultants (press release),...intensified doses of the chemotherapy regimen referred to as ICE (ifosfamide, carboplatin, and etoposide) improve median survival compared to standard

OSI Pharmaceuticals Announces European Regulatory Approval of ...  -  Feb 2, 2007
Oxfordshire Bioscience Network (press release),Tarceva with doublet platinum-based chemotherapy (carboplatin and paclitaxel or gemcitabine and cisplatin) and its use is not recommended in that setting.

Intensive Chemotherapy Regimen Shows Promise for Germ Cell Tumors  -  Feb 1, 2007
Cancer Consultants (press release),This regimen consisted of cycles of cisplatin, vincristine, bleomycin, and carboplatin, followed by one cycle of vincristin and bleomycin and three cycles

All patched up  -  Feb 1, 2007
Varsity (subscription),A PoLi implant is formulated to last for a specific amount of time, delivering the powerful drugs paclitaxel and carboplatin to the tumour site and breaking

CuraGen Reports Fourth Quarter and Year End 2006 Financial Results ...  -  Feb 1, 2007
Earthtimes.orgBelinostat (PXD101) - Preliminary Phase II results of intravenous belinostat in combination with carboplatin and paclitaxel for advanced ovarian cancer by

CuraGen Reports Fourth Quarter and Year End 2006 Financial Results ...  -  Feb 1, 2007
Yahoo! News (press release)Preliminary Phase II results of intravenous belinostat in combination with carboplatin and paclitaxel for advanced ovarian cancer by mid- 2007;

Adderall drives pharma division at Johnson Matthey  -  Jan 30, 2007
OutSourcing-Pharma.com,...which were due to drugs and controlled substances not being launched as expected and expiry of patents, such as carboplatin, a chemotherapy drug.

OSI Pharmaceuticals Announces European Regulatory Approval of ...  -  Jan 29, 2007
PharmaLive.com (press release),...with doublet platinum-based chemotherapy (carboplatin and paclitaxel or gemcitabine and cisplatin) and its use is not recommended in that setting.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional